EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
2.4.1.18 | 1,4-alpha-glucan branching enzyme |
HT-29 cell |
- |
660544 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
HT-29 cell |
- |
760802 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
HT-29 cell |
- |
668160, 695481, 695883, 697102 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
HT-29 cell |
colon cancer cell line |
667147 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
HT-29 cell |
very low enzyme expression level |
669380 |
3.1.4.35 | 3',5'-cyclic-GMP phosphodiesterase |
HT-29 cell |
colon cancer cell |
650811 |
2.4.1.65 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase |
HT-29 cell |
- |
704049, 736582 |
2.4.1.65 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase |
HT-29 cell |
very low expression of FUT1, FUT3, FUT6 and FUT9, low expression of FUT2, FUT5 and FUT10, higher expression of FUT4, highest expression of FUT11 |
704049 |
2.7.1.105 | 6-phosphofructo-2-kinase |
HT-29 cell |
- |
749587 |
7.6.2.2 | ABC-type xenobiotic transporter |
HT-29 cell |
- |
688594, 748695 |
2.4.1.147 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase |
HT-29 cell |
- |
736540 |
3.4.24.86 | ADAM 17 endopeptidase |
HT-29 cell |
- |
668102 |
4.1.1.50 | adenosylmethionine decarboxylase |
HT-29 cell |
- |
680578 |
1.1.1.21 | aldose reductase |
HT-29 cell |
- |
713006, 722714 |
3.1.3.1 | alkaline phosphatase |
HT-29 cell |
HT-29 cells from colon produce the intestinal isoenzyme |
94564 |
2.4.1.155 | alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase |
HT-29 cell |
- |
759884 |
3.2.1.51 | alpha-L-fucosidase |
HT-29 cell |
- |
655418 |
3.2.1.51 | alpha-L-fucosidase |
HT-29 cell |
cell colorectal cancer cells |
655733 |
2.8.2.1 | aryl sulfotransferase |
HT-29 cell |
culture with TNF-alpha increases activity of SULT1A1, TGF-beta increases activity to a lesser extent, insulin also increases activity of SULT1A1 |
663431 |
2.8.2.1 | aryl sulfotransferase |
HT-29 cell |
culture with TNF-alpha increases activity of SULT1A1, TGF-beta increases activity to a lesser extent, insulin does not increase activity of SULT1A3 |
663431 |
2.8.2.1 | aryl sulfotransferase |
HT-29 cell |
HT-29. Culture with TNF-alpha increases activity of SULT1A1, TGF-beta increases activity to a lesser extent, insulin also increases activity of SULT1A1 |
663431 |
2.8.2.1 | aryl sulfotransferase |
HT-29 cell |
HT-29. Culture with TNF-alpha increases activity of SULT1A1, TGF-beta increases activity to a lesser extent, insulin does not increase activity of SULT1A3 |
663431 |
2.3.1.5 | arylamine N-acetyltransferase |
HT-29 cell |
- |
756019, 756372, 756928, 757700, 758164 |
2.4.1.146 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase |
HT-29 cell |
- |
736540 |
2.4.1.146 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase |
HT-29 cell |
colonic carcinoma cell line |
638301 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
HT-29 cell |
- |
736540 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
HT-29 cell |
colonic adenocarcinoma cell line |
638140 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
HT-29 cell |
high levels of endogenous GCNT3 |
760171 |
2.4.3.2 | beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3-sialyltransferase |
HT-29 cell |
type 2 mRNA isoform, type 1 mRNA isoform is not detected |
744211 |
3.4.22.63 | caspase-10 |
HT-29 cell |
- |
753179 |
3.4.22.55 | caspase-2 |
HT-29 cell |
- |
711679 |
3.4.22.56 | caspase-3 |
HT-29 cell |
- |
707972, 709751 |
3.4.22.57 | caspase-4 |
HT-29 cell |
- |
731612 |
3.4.22.60 | caspase-7 |
HT-29 cell |
monolayer cell culture |
699310 |
3.4.22.62 | caspase-9 |
HT-29 cell |
- |
731609 |
3.4.22.1 | cathepsin B |
HT-29 cell |
- |
753225 |
2.8.2.5 | chondroitin 4-sulfotransferase |
HT-29 cell |
- |
737759 |
2.7.1.74 | deoxycytidine kinase |
HT-29 cell |
- |
672797, 721556 |
2.3.1.57 | diamine N-acetyltransferase |
HT-29 cell |
- |
757889 |
3.4.14.5 | dipeptidyl-peptidase IV |
HT-29 cell |
- |
682805 |
2.1.1.37 | DNA (cytosine-5-)-methyltransferase |
HT-29 cell |
colon cancer |
658383 |
5.6.2.1 | DNA topoisomerase |
HT-29 cell |
- |
3839, 691321, 691729, 702602, 705047, 714760, 747038, 748337 |
5.6.2.1 | DNA topoisomerase |
HT-29 cell |
colon cancer cell line |
693543 |
5.6.2.1 | DNA topoisomerase |
HT-29 cell |
HT-29 cells have five copies of the hTOPI gene, they show twofold less hTopI protein, and twofold lower activity of hTopI compared to Caco-2 cells, but similar camptothecin sensitivity |
728804 |
5.6.2.2 | DNA topoisomerase (ATP-hydrolysing) |
HT-29 cell |
- |
691245, 702602, 715842, 747038 |
5.6.2.2 | DNA topoisomerase (ATP-hydrolysing) |
HT-29 cell |
colon adenocarcinoma cell line |
661473 |
3.6.1.23 | dUTP diphosphatase |
HT-29 cell |
- |
667399 |
2.7.11.20 | elongation factor 2 kinase |
HT-29 cell |
- |
760308, 760810 |
2.7.7.14 | ethanolamine-phosphate cytidylyltransferase |
HT-29 cell |
- |
722415 |
2.3.1.85 | fatty-acid synthase system |
HT-29 cell |
- |
705999 |
3.1.3.46 | fructose-2,6-bisphosphate 2-phosphatase |
HT-29 cell |
- |
749587 |
4.1.2.13 | fructose-bisphosphate aldolase |
HT-29 cell |
- |
747985 |
1.3.1.6 | fumarate reductase (NADH) |
HT-29 cell |
colorectal cancer cells |
713389 |
3.4.21.75 | Furin |
HT-29 cell |
- |
708242 |
2.4.1.17 | glucuronosyltransferase |
HT-29 cell |
- |
757920 |
2.3.1.147 | glycerophospholipid arachidonoyl-transferase (CoA-independent) |
HT-29 cell |
- |
676922 |
3.1.4.50 | glycosylphosphatidylinositol phospholipase D |
HT-29 cell |
- |
664499 |
2.3.1.97 | glycylpeptide N-tetradecanoyltransferase |
HT-29 cell |
- |
657771 |
1.1.1.26 | glyoxylate reductase |
HT-29 cell |
cultured with tumor necrosis factor alpha |
739242 |
1.1.1.79 | glyoxylate reductase (NADP+) |
HT-29 cell |
- |
739242 |
1.1.1.79 | glyoxylate reductase (NADP+) |
HT-29 cell |
cultured with tumor necrosis factor alpha |
739242 |
3.4.21.B2 | granzyme M |
HT-29 cell |
- |
754951 |
7.1.2.2 | H+-transporting two-sector ATPase |
HT-29 cell |
- |
734201 |
1.14.14.18 | heme oxygenase (biliverdin-producing) |
HT-29 cell |
- |
733488 |
3.2.1.166 | heparanase |
HT-29 cell |
- |
714936 |
2.3.1.48 | histone acetyltransferase |
HT-29 cell |
colon tumor cell line |
675911 |
3.5.1.98 | histone deacetylase |
HT-29 cell |
- |
680626, 711682 |
3.1.1.79 | hormone-sensitive lipase |
HT-29 cell |
- |
654402 |
1.5.5.3 | hydroxyproline dehydrogenase |
HT-29 cell |
- |
742832 |
1.1.1.81 | hydroxypyruvate reductase |
HT-29 cell |
- |
739242 |
2.4.2.8 | hypoxanthine phosphoribosyltransferase |
HT-29 cell |
- |
759769 |
3.5.4.10 | IMP cyclohydrolase |
HT-29 cell |
- |
668561 |
1.1.1.205 | IMP dehydrogenase |
HT-29 cell |
- |
711518 |
3.4.21.B41 | kallikrein 10 |
HT-29 cell |
- |
718439 |
3.4.21.B45 | kallikrein 14 |
HT-29 cell |
- |
717068 |
3.4.11.1 | leucyl aminopeptidase |
HT-29 cell |
- |
665925 |
3.3.2.6 | leukotriene-A4 hydrolase |
HT-29 cell |
- |
752495 |
3.4.24.65 | macrophage elastase |
HT-29 cell |
- |
733603 |
3.4.24.23 | matrilysin |
HT-29 cell |
- |
683334, 707569, 708011, 709073, 717204, 755514 |
3.4.24.23 | matrilysin |
HT-29 cell |
LN5 and MMP7 are coexpressed in HT29 cells, as well as in HT29 xenograft tumors and human colorectal adenocarcinomas, distribution, overview |
683329 |
3.4.24.23 | matrilysin |
HT-29 cell |
MMP-7 expression analysis in estrogen-dependently proliferating cells, overview |
709318 |
3.4.24.23 | matrilysin |
HT-29 cell |
wild-type HT-29 and oxaliplatin-resistant RHT-29 cell lines |
710360 |
3.4.24.B3 | matrix metalloproteinase-11 |
HT-29 cell |
- |
718998 |
2.5.1.6 | methionine adenosyltransferase |
HT-29 cell |
- |
686924 |
3.4.11.18 | methionyl aminopeptidase |
HT-29 cell |
- |
709910 |
3.4.11.18 | methionyl aminopeptidase |
HT-29 cell |
and HCT-116 cell, highest expression levels found |
670444 |
3.4.11.18 | methionyl aminopeptidase |
HT-29 cell |
colon cancer cell line, expression of enzyme is inversely correlated to cell density |
657771 |
2.1.1.63 | methylated-DNA-[protein]-cysteine S-methyltransferase |
HT-29 cell |
- |
675596, 734821 |
2.7.11.24 | mitogen-activated protein kinase |
HT-29 cell |
- |
703019 |
2.7.12.2 | mitogen-activated protein kinase kinase |
HT-29 cell |
- |
740419 |
2.4.1.244 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase |
HT-29 cell |
- |
736917 |
2.4.1.150 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase |
HT-29 cell |
high levels of endogenous GCNT3 |
760171 |
2.3.1.257 | N-terminal L-serine Nalpha-acetyltransferase NatD |
HT-29 cell |
- |
735456, 756385 |
1.6.5.2 | NAD(P)H dehydrogenase (quinone) |
HT-29 cell |
- |
711167, 713005, 744485 |
3.4.24.16 | neurolysin |
HT-29 cell |
colon cancer cell line |
683961 |
2.1.1.1 | nicotinamide N-methyltransferase |
HT-29 cell |
- |
704775, 757887 |
2.1.1.1 | nicotinamide N-methyltransferase |
HT-29 cell |
colon cancer cells with high and constitutive expression of NNMT |
687897 |
2.1.1.1 | nicotinamide N-methyltransferase |
HT-29 cell |
exhibit high endogenous expression of enzyme NNMT |
733214 |
2.4.2.12 | nicotinamide phosphoribosyltransferase |
HT-29 cell |
- |
736436 |
2.7.7.1 | nicotinamide-nucleotide adenylyltransferase |
HT-29 cell |
- |
737971 |